(NASDAQ:ACAD) earned "Buy" rating by Needham on Friday, August 7. Approximately 27.6% of the company's stock are short sold. The firm has "Buy" rating given on Monday, July 31 by UBS. Share performance for the month is now at …
Its down 0.14, from 1.2 in 2016Q3. Finally, ValuEngine raised shares of ACADIA …
The average 12 month target price among brokers that have covered the stock in …
Zurcher Kantonalbank (Zurich Cantonalbank), a Switzerland-based fund reported 11,737 shares. (ACAD) is -0.55 while the analysts predicted the EPS of the stock to be -0.72 suggesting the company fell short of the analysts' expectations. …
Two investment analysts have rated the stock with a sell rating, five have issued a …
The stock of NXP Semiconductors NV (NASDAQ ... HC Wainwright reiterated their buy recommendation on stocks of ACADIA Pharmaceuticals (NASDAQ:ACAD) in a study report released on Wednesday. The Company is focused on the …
ACHN closed Tuesday's trading at $4.01, up 1.01%. In after-hours, the stock was …
Quarterly disclosures of hedge fund managers' stock holdings, in what are known …